Effect of the glucagon-like peptide-1 receptor agonist lixisenatide on postprandial hepatic glucose metabolism in the conscious dog

Por Moore, Mary Courtney, Werner, Ulrich, Smith, Marta S., Farmer, Tiffany D., Cherrington, Alan D.
Publicado em 2013

Effect of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog

Por Edgerton, Dale S., Basu, Rita, Ramnanan, Christopher J., Farmer, Tiffany D., Neal, Doss, Scott, Melanie, Jacobson, Peer, Rizza, Robert A., Cherrington, Alan D.
Publicado em 2010

Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp

Por Farmer, Tiffany D., Jenkins, Erin C., O'Brien, Tracy P., McCoy, Gregory A., Havlik, Allison E., Nass, Erik R., Nicholson, Wendell E., Printz, Richard L., Shiota, Masakazu
Publicado no Am J Physiol Endocrinol Metab (2014)

Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs

Por Ramnanan, Christopher J., Saraswathi, Viswanathan, Smith, Marta S., Donahue, E. Patrick, Farmer, Ben, Farmer, Tiffany D., Neal, Doss, Williams, Philip E., Lautz, Margaret, Mari, Andrea, Cherrington, Alan D., Edgerton, Dale S.
Publicado em 2011

Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity

Por Ueta, Kiichiro, O'Brien, Tracy P., McCoy, Gregory A., Kim, Kuikwon, Healey, Erin C., Farmer, Tiffany D., Donahue, E. Patrick, Condren, Audree B., Printz, Richard L., Shiota, Masakazu
Publicado em 2014

Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal M...

Por O’Brien, Tracy P., Jenkins, Erin C., Estes, Shanea K., Castaneda, Antonio V., Ueta, Kiichiro, Farmer, Tiffany D., Puglisi, Allison E., Swift, Larry L., Printz, Richard L., Shiota, Masakazu
Publicado no Diabetes (2017)